Home/Filings/4/0001437749-24-026999
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-24-026999

CIK 0000880242other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 3:13 PM ET

Size

14.1 KB

Accession

0001437749-24-026999

Insider Transaction Report

Form 4
Period: 2024-08-13
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option

    2024-08-13+300,0004,625,786 total
    Exercise: $0.24From: 2024-08-13Exp: 2034-08-13common stock (300,000 underlying)
Footnotes (2)
  • [F1]The Option vests in equal monthly installments of 25,000 shares, so long as the Engagement Extension Agreement dated August 13, 2024, between Reporting Person and Issuer, remains in force and effect.
  • [F2]This Option was issued to the Reporting Person as compensation to serve as Issuer's Chief Financial Officer from February 1, 2024, through January 31, 2025.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 3:13 PM ET
Size
14.1 KB